In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Arakis closes £29mm third round

Executive Summary

Specialty pharmaceutical company Arakis Ltd. raised £29mm ($51.5mm) in a third financing round, which was led by Novo AS and Scottish Equity Partners. Additional new investors Scottish Widows Investment Partnership, Finsbury Life Sciences, and Close Finsbury Eurotech participated along with returning shareholders Nomura Phase4 Ventures, 3i, Merlin Biosciences, and MB Venture Capital. Company management and directors also contributed.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies